| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 7e-05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |